Animal Model Market by Type (Amphibian Models, Avian Models, Fish Models), Application (Behavioral Studies, Cancer Research, Disease Research), End-Users - Global Forecast 2024-2030

Animal Model Market by Type (Amphibian Models, Avian Models, Fish Models), Application (Behavioral Studies, Cancer Research, Disease Research), End-Users - Global Forecast 2024-2030

The Animal Model Market size was estimated at USD 2.94 billion in 2023 and expected to reach USD 3.16 billion in 2024, at a CAGR 8.00% to reach USD 5.03 billion by 2030.

An animal model involves using certain animals to study human biology and disease. Researchers use these models to explore various health concerns, including the mechanisms of diseases and possible treatments, before these treatments are tested on humans. This approach rests on the assumption that many biological and physiological processes in animals are sufficiently similar to those in humans. Rising pharmaceutical and biomedical research activities by pharmaceutical and biopharmaceutical companies are driving the usage of animal models. Rising advancements in genetic engineering, including, CRISPR, have expanded the capabilities of animal models. Scientists can now alter animal genes to more closely mimic human diseases, which helps in more targeted and valuable studies. Ethical concerns and the availability of alternatives to animal testing associated with animal models hampers the market growth. Rising advancements in genetic engineering and biotechnology that facilitate the development of more sophisticated and diverse animal models that can mimic human diseases more accurately are expected to create opportunities for market growth. This enhances their utility in a broader range of applications, from basic research to applied commercial studies, thereby broadening market reach and penetration.

Regional Insights

The animal model market in the Americas is highly developed due to strong research infrastructure and significant investment in biomedical research. The use of various animals such as mice, rats, and other species in research activities is prevalent due to the established guidelines and ethical standards. This region leads in innovative research techniques, including genetic engineering and CRISPR technology, contributing to a robust animal model market. The APAC region is experiencing rapid growth in the animal model market driven by increasing investment in healthcare research, rising demand for personalized medicine, and expanding pharmaceutical and biotechnology industries, especially in countries such as China, Japan, and India. There is a growing awareness of the importance of standard and ethically sourced animal models influencing market trends within APAC. European countries have stringent animal research regulations promoting the use of more ethically sourced and well-cared-for animals. The focus is developing alternative methods to reduce animal usage in experiments. Despite these challenges, Europe maintains a strong market presence due to its advanced scientific research infrastructure. The market is growing in the Middle East and parts of Africa, influenced by increasing research initiatives and infrastructure development.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Animal Model Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

• Rising prevalence of chronic diseases necessitating long-term research studies
• Increasing demand for personalized medicine and genomic research
• Growth in biopharmaceutical and contract research activities across economies

Market Restraints

• High costs associated with developing and maintaining animal models

Market Opportunities

• Technological advancements in genetic modification techniques
• Supportive governmental and regulatory frameworks to boost biomedical research

Market Challenges

• Complexities in animal model development and ethical concerns

Market Segmentation Analysis

• Type: Growing usage of amphibians due to their unique developmental properties and simple body plans
• End-Users: High potential for animal models across academic research institutes to understand disease mechanisms and study the effects of new drugs

Market Disruption Analysis

• Porter’s Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Animal Model Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Animal Model Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Biocytogen Forms Strategic Alliance with Neurocrine Biosciences for Antibody Development

Biocytogen Pharmaceuticals Co., Ltd recently entered an evaluation and option agreement with Neurocrine Biosciences, Inc., providing Neurocrine access to a selection of fully human antibodies from Biocytogen's RenMice platforms. This agreement allows Neurocrine to potentially license these antibodies for worldwide therapeutic development, manufacturing, and commercialization.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Animal Model Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Animal Model Market, highlighting leading vendors and their innovative profiles. These include Applied Stemcell Inc., Aragen Life Sciences Ltd., Biocytogen Boston Corp,, Charles River Laboratories International, Inc., Creative Animodel, Creative Biolabs, Crescendo Biologics Ltd., Cyagen US Inc., GenOway S.A., HBM Holdings, Ingenious Targeting Laboratory, Inotiv, Inc., Janvier Labs, JOINN Laboratories (China) Co., Ltd., JSR Corporation, Marshall BioResources, Ozgene Pty Ltd., PolyGene, Taconic Biosciences, Inc., The Jackson Laboratory, Trans Genic Inc., TransCure Bioservices, and Vivo Bio Tech Ltd..

Market Segmentation & Coverage

This research report categorizes the Animal Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
• Amphibian Models
• Frogs
• Salamanders
• Avian Models
• Chickens
• Zebra Finches
• Fish Models
• Medaka
• Zebrafish
• Invertebrate Models
• Fruit Flies
• Nematodes
• Mammalian Models
• Mice
• Rabbits & Guinea Pigs
• Rats
• Reptile Models
• Lizards
• Snakes
• Application
• Behavioral Studies
• Cancer Research
• Disease Research
• Drug & Vaccine Development
• Environmental Health Studies
• Genetic Studies
• End-Users
• Academic Research Institutes
• Pharmaceutical & Biotechnology Companies
• Region
• Americas
• Argentina
• Brazil
• Canada
• Mexico
• United States
• California
• Florida
• Illinois
• New York
• Ohio
• Pennsylvania
• Texas
• Asia-Pacific
• Australia
• China
• India
• Indonesia
• Japan
• Malaysia
• Philippines
• Singapore
• South Korea
• Taiwan
• Thailand
• Vietnam
• Europe, Middle East & Africa
• Denmark
• Egypt
• Finland
• France
• Germany
• Israel
• Italy
• Netherlands
• Nigeria
• Norway
• Poland
• Qatar
• Russia
• Saudi Arabia
• South Africa
• Spain
• Sweden
• Switzerland
• Turkey
• United Arab Emirates
• United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year